SERPINA1 and bacterial infectious disease: Actually, these data show that augmentation therapy of S. pneumoniae–infected AAT-KO mice improved survival by effectively diminishing lung bacterial loads and the release of proinflammatory cytokines, which — in addition to the bacterial infection — may significantly contribute to lung damage.